Last update 01 Nov 2024

RojanPharma Pharmaceutical Company

Private Company

Overview

Tags

Digestive System Disorders
Infectious Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
NS5A x NS5B polymerase1

Related

1
Drugs associated with RojanPharma Pharmaceutical Company
Daclatasvir/Sofosbuvir
Target
NS5A x NS5B polymerase
Mechanism
NS5A inhibitors [+1]
Active Org.
The Johns Hopkins UniversityThe Johns Hopkins University [+1]
Originator Org.
RojanPharma Pharmaceutical Company
Active Indication
Hepatitis C, Chronic
Inactive Indication
Chronic hepatitis C genotype 3
Drug Highest PhaseApproved
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with RojanPharma Pharmaceutical Company
NCT03369327 / CompletedPhase 3IIT
Efficacy of a Fixed-Dose Combination Pill of Sofosbuvir and Daclatasvir in Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency Virus
100 Clinical Results associated with RojanPharma Pharmaceutical Company
Login to view more data
0 Patents (Medical) associated with RojanPharma Pharmaceutical Company
Login to view more data
100 Deals associated with RojanPharma Pharmaceutical Company
Login to view more data
100 Translational Medicine associated with RojanPharma Pharmaceutical Company
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 17 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Daclatasvir/Sofosbuvir
 ( NS5A x NS5B polymerase )		Hepatitis C, Chronic
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free